These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

852 related items for PubMed ID: 23171357

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL, Liu YH, Zhang F, Xu FP, Yan LX, Chen J, Xu J, Luo XL, Zhuang HG.
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [Abstract] [Full Text] [Related]

  • 3. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
    Gebauer N, Bernard V, Feller AC, Merz H.
    Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
    [Abstract] [Full Text] [Related]

  • 4. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
    Haralambieva E, Boerma EJ, van Imhoff GW, Rosati S, Schuuring E, Müller-Hermelink HK, Kluin PM, Ott G.
    Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
    [Abstract] [Full Text] [Related]

  • 5. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH.
    Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
    [Abstract] [Full Text] [Related]

  • 6. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
    Li S, Desai P, Lin P, Yin CC, Tang G, Wang XJ, Konoplev SN, Khoury JD, Bueso-Ramos CE, Medeiros LJ.
    Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations.
    Johnson SM, Umakanthan JM, Yuan J, Fedoriw Y, Bociek RG, Kaiser-Rogers K, Sanmann JN, Montgomery ND.
    Hum Pathol; 2018 Oct; 80():192-200. PubMed ID: 29902576
    [Abstract] [Full Text] [Related]

  • 12. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.
    Aukema SM, Kreuz M, Kohler CW, Rosolowski M, Hasenclever D, Hummel M, Küppers R, Lenze D, Ott G, Pott C, Richter J, Rosenwald A, Szczepanowski M, Schwaenen C, Stein H, Trautmann H, Wessendorf S, Trümper L, Loeffler M, Spang R, Kluin PM, Klapper W, Siebert R, Molecular Mechanisms in Malignant Lymphomas Network Project.
    Haematologica; 2014 Apr; 99(4):726-35. PubMed ID: 24179151
    [Abstract] [Full Text] [Related]

  • 13. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W, Hu S, Lu X, Young KH, Medeiros LJ.
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [Abstract] [Full Text] [Related]

  • 14. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas.
    Wongchaowart NT, Kim B, Hsi ED, Swerdlow SH, Tubbs RR, Cook JR.
    J Cutan Pathol; 2006 Apr; 33(4):286-92. PubMed ID: 16630178
    [Abstract] [Full Text] [Related]

  • 15. Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
    Hori Y, Yamamoto H, Nozaki Y, Torisu T, Fujiwara M, Taguchi K, Nishiyama K, Nakamura S, Kitazono T, Oda Y.
    Hum Pathol; 2020 Feb; 96():67-78. PubMed ID: 31734190
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
    Bürgesser MV, Gualco G, Diller A, Natkunam Y, Bacchi CE.
    Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements.
    Yoshida M, Ichikawa A, Miyoshi H, Kiyasu J, Kimura Y, Arakawa F, Niino D, Ohshima K.
    Pathol Int; 2015 Oct; 65(10):519-27. PubMed ID: 26224092
    [Abstract] [Full Text] [Related]

  • 18. Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.
    Agarwal R, Lade S, Liew D, Rogers TM, Byrne D, Feleppa F, Juneja S, Westerman DA.
    J Clin Pathol; 2016 Mar; 69(3):266-70. PubMed ID: 26307073
    [Abstract] [Full Text] [Related]

  • 19. Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis.
    Lynnhtun K, Renthawa J, Varikatt W.
    Pathology; 2014 Apr; 46(3):211-5. PubMed ID: 24614699
    [Abstract] [Full Text] [Related]

  • 20. Screening Strategy for Detecting Double-Hit Lymphoma in a Resource-Limited Setting.
    Thirunavukkarasu B, Bal A, Prakash G, Malhotra P, Singh H, Das A.
    Appl Immunohistochem Mol Morphol; 2022 Jan 01; 30(1):49-55. PubMed ID: 34456240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.